HYPM inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of **HYPM**, a protein involved in the regulation of cellular metabolism, protein synthesis, and intracellular signaling. HYPM is believed to play a role in modulating key pathways that control energy balance, protein homeostasis, and the response to cellular stress. By inhibiting HYPM, these compounds disrupt the normal functioning of these regulatory pathways, allowing researchers to explore how changes in HYPM activity affect various aspects of cellular physiology. This inhibition provides a useful tool for studying the molecular interactions and processes that are influenced by HYPM, including its potential roles in protein synthesis, metabolic regulation, and cellular adaptation to changing environmental conditions.
The use of HYPM inhibitors in research allows scientists to investigate the broader implications of altered protein regulation and metabolic balance within cells. By blocking HYPM, researchers can observe the downstream effects on cellular processes such as energy production, protein folding, and the activation of signaling networks involved in maintaining homeostasis. This helps to reveal the underlying mechanisms by which HYPM influences cellular metabolism and stress responses, and how its inhibition leads to changes in protein function and cellular behavior. Additionally, HYPM inhibitors offer insights into the complex interplay between protein regulators and metabolic pathways, shedding light on how cells coordinate these essential functions to ensure survival and growth. Through these studies, HYPM inhibitors contribute to a deeper understanding of the molecular mechanisms governing cellular metabolism and protein regulation.
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor. By inhibiting Aurora kinases, it affects the cell cycle and mitotic spindle assembly. Since HYPM is involved in cell cycle regulation, inhibition of Aurora kinases can lead to the indirect inhibition of HYPM. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Is a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), which are essential for cell cycle progression. Inhibiting these kinases can lead to the downregulation of cell cycle-related pathways that control the regulation and function of HYPM. | ||||||